Literature DB >> 25740595

Interleukin-22 in kidney injury and regeneration.

Marc Weidenbusch1, Severin Rodler1, Hans-Joachim Anders2.   

Abstract

Interleukins have become well-known regulators of innate and adaptive immunity-related tissue inflammation. Recently, IL-22 has gained a lot of interest for its unique functions in maintaining and regaining epithelial integrity. IL-22 is exclusively secreted by different immune cell subsets, while IL-22 receptors are mainly expressed by epithelial cells. As the kidney is largely an epithelial organ, the functional role of IL-22 in the kidney deserves to be explored in detail. Here, we briefly summarize the key features of IL-22 biology and review the available data on its expression and functional roles in kidney injury and kidney regeneration. Furthermore, we provide suggestions on how to explore this evolving field in the future.
Copyright © 2015 the American Physiological Society.

Entities:  

Keywords:  AKI; CKD; healing; immunoepithelial cross talk; inflammation; repair; stem cells

Mesh:

Substances:

Year:  2015        PMID: 25740595     DOI: 10.1152/ajprenal.00005.2015

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  11 in total

1.  P27 deletion enhances hematopoiesis by paracrine action of IL22 secreted from bone marrow mesenchymal stem cells.

Authors:  Ruinan Lu; Qian Wang; Jianyong Li; Dengshun Miao
Journal:  Am J Transl Res       Date:  2020-03-15       Impact factor: 4.060

2.  Transplantation of umbilical cord mesenchymal stem cells into mice with focal segmental glomerulosclerosis delayed disease manifestation.

Authors:  Yifan Shi; Jingyuan Xie; Mingxin Yang; Jun Ma; Hong Ren
Journal:  Ann Transl Med       Date:  2019-08

Review 3.  The Immune System in Tissue Environments Regaining Homeostasis after Injury: Is "Inflammation" Always Inflammation?

Authors:  Onkar P Kulkarni; Julia Lichtnekert; Hans-Joachim Anders; Shrikant R Mulay
Journal:  Mediators Inflamm       Date:  2016-08-11       Impact factor: 4.711

Review 4.  Issues of Acute Kidney Injury Staging and Management in Sepsis and Critical Illness: A Narrative Review.

Authors:  Christian Nusshag; Markus A Weigand; Martin Zeier; Christian Morath; Thorsten Brenner
Journal:  Int J Mol Sci       Date:  2017-06-28       Impact factor: 5.923

5.  Serum levels of interleukin-22, cardiometabolic risk factors and incident type 2 diabetes: KORA F4/FF4 study.

Authors:  Christian Herder; Julia M Kannenberg; Maren Carstensen-Kirberg; Cornelia Huth; Christa Meisinger; Wolfgang Koenig; Annette Peters; Wolfgang Rathmann; Michael Roden; Barbara Thorand
Journal:  Cardiovasc Diabetol       Date:  2017-01-31       Impact factor: 9.951

Review 6.  Bioactive Compounds for the Treatment of Renal Disease.

Authors:  Kang Su Cho; In Kap Ko; James J Yoo
Journal:  Yonsei Med J       Date:  2018-11       Impact factor: 2.759

7.  IL-22 sustains epithelial integrity in progressive kidney remodeling and fibrosis.

Authors:  Marc Weidenbusch; Shangqing Song; Takamasa Iwakura; Chongxu Shi; Severin Rodler; Sebastian Kobold; Shrikant R Mulay; Mohsen M Honarpisheh; Hans-Joachim Anders
Journal:  Physiol Rep       Date:  2018-08

Review 8.  Renal Inflammation and Fibrosis: A Double-edged Sword.

Authors:  Laurence M Black; Jeremie M Lever; Anupam Agarwal
Journal:  J Histochem Cytochem       Date:  2019-05-22       Impact factor: 2.479

9.  Gene expression profiling of the Notch-AhR-IL22 axis at homeostasis and in response to tissue injury.

Authors:  Marc Weidenbusch; Severin Rodler; Shangqing Song; Simone Romoli; Julian A Marschner; Franziska Kraft; Alexander Holderied; Santosh Kumar; Shrikant R Mulay; Mohsen Honarpisheh; Satish Kumar Devarapu; Maciej Lech; Hans-Joachim Anders
Journal:  Biosci Rep       Date:  2017-12-22       Impact factor: 3.840

10.  Interleukin-22 ameliorated renal injury and fibrosis in diabetic nephropathy through inhibition of NLRP3 inflammasome activation.

Authors:  Shaofei Wang; Yubin Li; Jiajun Fan; Xuyao Zhang; Jingyun Luan; Qi Bian; Tao Ding; Yichen Wang; Ziyu Wang; Ping Song; Daxiang Cui; Xiaobin Mei; Dianwen Ju
Journal:  Cell Death Dis       Date:  2017-07-20       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.